FOGHORN THERAPEUTICS INC (FHTX) Stock Cash Flow
NASDAQ:FHTX - Nasdaq - US3441741077 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -91.22M | -98.43M | -108.90M | -101.30M | -68.80M | |||
| Depreciation Amortization | 3.21M | 3.45M | 3.30M | 3.20M | 1.30M | |||
| Change In Working Capital | -32.43M | -41.88M | 281.50M | 33.40M | 28.70M | |||
| Interest Paid | N/A | N/A | 0.00 | 1.70M | 700.00K | |||
| Taxes Paid | 1.66M | 3.55M | N/A | N/A | N/A | |||
| Other non cash items | 16.97M | 18.75M | 17.60M | 14.40M | 7.50M | |||
| OPERATING CASH FLOW | -103.39M | -118.11M | 193.60M | -50.30M | -31.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -451.00K | -1.22M | -1.20M | -3.30M | -16.20M | |||
| Other Investing Activity | -14.39M | 145.67M | -243.10M | 39.50M | -92.70M | |||
| INVESTING CASH FLOW | -14.85M | 144.45M | -244.30M | 36.20M | -108.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -21.20M | 4.30M | |||
| Stock Issued/Repurchased | 106.19M | 1.78M | 1.80M | 1.40M | 213.20M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 42.20M | N/A | |||
| FINANCING CASH FLOW | 105.60M | 1.78M | 1.80M | 22.40M | 217.50M | |||
| CHANGE IN CASH | -12.64M | 28.12M | -48.90M | 8.30M | 77.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -103.39M | -118.11M | 193.60M | -50.30M | -31.30M | |||
| Capital Expenditure | -451.00K | -1.22M | -1.20M | -3.30M | -16.20M | |||
| FREE CASH FLOW | -103.84M | -119.33M | 192.40M | -53.60M | -47.50M | |||
All data in USD